Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma

Zeev Blumenfeld(Rappaport Family Institute for Research in the Medical Sciences), Eldad J. Dann(Rambam Health Care Campus), Ari Eckman(Technion – Israel Institute of Technology), Jacob M. Rowe(Technion – Israel Institute of Technology), Ron Epelbaum(University of Bern), Irith Avivi(Technion – Israel Institute of Technology)
Fertility and Sterility
June 29, 2007
10.1016/j.fertnstert.2007.02.010
Cited by 179

Related Papers

Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
|Blood|2006|843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
|Blood|2007|782
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
|Blood|2006|746